BELLEVUE LIFE SCIENCES ACQUISITION CORP.

Bellevue Life Sciences Acquisition Corp.

BLAC

US0791741087

Investment Holding Companies

Market Closed - Nasdaq Other stock markets 21:30:00 22/05/2024 BST			5-day change	1st Jan Change
10.73 ^USD	0.00%		-0.28%	+2.19%

05-14	Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding	CI
04-17	Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022

March 31, 2023 at 09:16 pm

Bellevue Life Sciences Acquisition Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 0.035388 million compared to USD 0.003308 million a year ago.

Basic loss per share from continuing operations was USD 0.01.

Latest news about Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding	05-13	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-17	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.05 million in funding	04-16	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $1.2 million in funding	04-07	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.06 million in funding	03-07	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.075 million in funding	02-08	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Certain Common Stock of Bellevue Life Sciences Acquisition Corp. are subject to a Lock-Up Agreement Ending on 9-AUG-2023.	08/08/23	CI
Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal	11/07/23	MT
Bellevue Life Sciences Acquisition Corp. entered into an exclusive, non-binding letter of intent to acquire OSR Holdings, Ltd.	10/07/23	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.2 million in funding	22/06/23	CI
Bellevue Life Sciences Acquisition Corp. Announces the Resignation of Hosun Euh as Member of the Board of Directors, Effective June 21, 2023	14/06/23	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Bellevue Life Sciences Acquisition Corp. Auditor Raises 'Going Concern' Doubt	30/03/23	CI
Bellevue Life Sciences Acquisition Corp.(NasdaqCM:BLAC) added to NASDAQ Composite Index	20/03/23	CI
Bellevue Life Sciences Acquisition Corp. has completed an IPO in the amount of $60 million.	09/02/23	CI
Bellevue Life Sciences Acquisition Corp. has filed an IPO in the amount of $60 million.	29/04/22	CI

Chart Bellevue Life Sciences Acquisition Corp.

Duration

Period

Chart Bellevue Life Sciences Acquisition Corp.

More charts

Company Profile

Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
BELLEVUE LIFE SCIENCES ACQUISITION CORP.	+2.19%	60.33M
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+154.80%	6.1B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+26.41%	826M
ARES ACQUISITION CORPORATION II	+2.11%	666M
E7 GROUP	+5.03%	637M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+7.78%	524M
CAPITOL INVESTMENT CORP. VII	-.--%	500M